Phase II clinical and pharmacokinetic study of exatecan mesylate (DX-8951f) in patients with advanced ovarian cancer, refractory to, or relapsed after platinum and taxane.

  1. Lookup NU author(s)
  2. Dr Paula Calvert
  3. Professor Alan Calvert
Author(s)Calvert, P., Jayson, G., Atkinson, R., Ganesan, T., Cervantes-Ruiperez, A., Vasey, P., Adams, M., Boven, E., Calvert, A. H., Cheverton, P.
Editor(s)
Publication type Conference Proceedings (inc. Abstract)
Conference Name25th Anniversary ESMO Congress
Conference LocationHamburg, Germany
Year of Conference2000
Date13-17 OCtober 2000
Volume11 Supplement 4
Pages84 no. 372
0923-7534
ISBN
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
PublisherAnnals of Oncology: Oxford University Press
URLhttp://dx.doi.org/10.1093/annonc/11.suppl_4.81
DOI10.1093/annonc/11.suppl_4.81
Actions    Link to this publication
Library holdingsSearch Newcastle University Library for this item